Medindia LOGIN REGISTER
Medindia
Advertisement

Valor Medical Receives CE Mark for Neucrylate AN™ for Treating Cerebral Aneurysms

Thursday, May 12, 2011 General News
Advertisement
SAN DIEGO, May 11, 2011 /PRNewswire/ -- Valor Medical announced today that it has received CE Mark approval for Neucrylate AN for treating cerebral aneurysms.
Advertisement

Neucrylate AN is a liquid embolic device that is injected through a microinfusion catheter into the aneurysm.  When Neucrylate AN comes in contact with the blood in the aneurysm it immediately changes from a liquid into a porous, elastic, sponge like material.  Unlike conventional micro-coils used for treating cerebral aneurysms Neucrylate AN fills the entire aneurysm – regardless of its size or shape.  
Advertisement

Charles Kerber, M.D., founder and Chief Medical Officer stated, "Neucrylate AN will be another tool for treating cerebral aneurysms, especially those with wide necks and the larger aneurysms of complicated shape.  During the clinical trials the time to treat patients was reduced from hours to minutes, which should increase the surgery's safety, and certainly decreased the radiation dose."

"The CE Mark approval for Neucrylate AN in Europe is a major accomplishment for Valor Medical.  We look forward to beginning commercialization activities and will begin training physicians next month in Budapest, Hungary," said H. Clark Adams, Chief Executive Officer

For additional information visit Valor Medical's web site, www.valormedical.com.

SOURCE Valor Medical

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close